Verrica Pharmaceuticals Inc. Common Stock (VRCA) Stock Price, Quote & AI Analysis
Live VRCA stock price, real-time charts, AI-powered analysis, technical analysis, earnings insights, and market sentiment for Verrica Pharmaceuticals Inc. Common Stock.
TradeVae provides AI-driven analysis and real-time market intelligence for Verrica Pharmaceuticals Inc. Common Stock (VRCA), including price action, technical indicators, earnings performance, analyst sentiment, and risk-aware market context.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
Verrica Pharmaceuticals Inc. Common Stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
Verrica Pharmaceuticals Inc. Common Stock Overview
Company information
Company Overview
Verrica Pharmaceuticals, Inc. is a dermatology therapeutics company, which engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its products include Pipeline VP-102, Pipeline VP-103, and Pipeline VP-315. The company was founded by Matthew Davidson on July 3, 2013 and is headquartered in West Chester, PA.
Company Details
Technical Indicators
Key technical analysis metrics and indicators
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
Verrica Pharmaceuticals Inc. Common Stock Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...